Skip to the page

Data / Drug companies / Granules India Limited

Granules India Limited: 156 products in the FDA NDC directory, labeler code 62207

Updated November 6, 2026. Source: US Food and Drug Administration, National Drug Code Directory (openFDA).

Granules India Limited (labeler code 62207) lists 156 products in the FDA National Drug Code Directory, covering 21 finished drugs by generic name. By type: 53 drugs for further processing, 44 bulk ingredients. Its main marketing category is generic drugs (ANDA). The newest product started marketing on October 28, 2026.

The request: Watch Granules India Limited (FDA labeler code 62207): each new product listing and each discontinued product. $10 of work on sign-up, no card.

SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.

Labeler code
62207
Products in commercial distribution
156
Packages
435
Finished drugs by generic name
21
Prescription products
26
Over the counter products
33
Controlled substance products
Schedule II 1
Flagged as original packager
31 of 31 products that carry the flag
Started marketing in the last 12 months
13
Earliest marketing start
May 12, 2009
openFDA record search
api.fda.gov

Products by marketing category

Share of the company's products in commercial distribution.

Marketing categoryProductsShare
Generic drugs (ANDA)5937.8%
Drugs for further processing4528.8%
Bulk ingredients3723.7%
Export only159.6%

Products by type

TypeProductsShare
Drugs for further processing5334%
Bulk ingredients4428.2%
Over the counter drugs3321.2%
Prescription drugs2616.7%

Drugs it lists

Finished drugs by generic name, with how many companies list each.

Dosage forms

Dosage formProductsShare
Powder7749.4%
Tablet4025.6%
Tablet, extended release1610.3%
Tablet, film coated138.3%
Granule31.9%
Tablet, coated31.9%
Capsule, extended release21.3%
Capsule10.6%
Capsule, gelatin coated10.6%

Pharmacologic classes

FDA established pharmacologic classes of its products.

Newest products

By marketing start date.

ProductProduct NDCDosage formMarketing categoryMarketing start
Resmetirom62207-998PowderBulk ingredientsOctober 28, 2026
Elacestrant dihydrochloride62207-997PowderBulk ingredientsAugust 21, 2026
Acetaminophen62207-892Tablet, extended releaseGeneric drugs (ANDA)April 16, 2026
Gabapentin62207-996PowderBulk ingredientsMarch 30, 2026
Serdexmethylphendiate chloride62207-027PowderBulk ingredientsFebruary 27, 2026
Calcium oxybate62207-994PowderDrugs for further processingDecember 26, 2025
Potassium oxybate62207-993PowderDrugs for further processingDecember 26, 2025
Trazodone hydrochloride (common lubricated blend)62207-615GranuleExport onlyDecember 24, 2025
Magnesium oxybate62207-995PowderDrugs for further processingDecember 1, 2025
Sodium oxybate62207-992PowderDrugs for further processingDecember 1, 2025
Empagliflozin62207-026PowderBulk ingredientsDecember 1, 2025
Dapagliflozin62207-021PowderDrugs for further processingNovember 14, 2025
Olmesartan medoxomil62207-018PowderBulk ingredientsNovember 10, 2025
Metoprolol Succinate62207-130Tablet, extended releaseGeneric drugs (ANDA)August 1, 2025
Ruxolitinib phosphate62207-991PowderDrugs for further processingJuly 7, 2025
Ruxolitinib hydrochloride62207-990PowderDrugs for further processingJuly 7, 2025
Viloxazine hydrochloride62207-989PowderDrugs for further processingJuly 7, 2025
Paracetamol ph.eur62207-934PowderBulk ingredientsApril 14, 2025
Losartan Potassium62207-743TabletGeneric drugs (ANDA)March 18, 2025
Losartan Potassium62207-741TabletGeneric drugs (ANDA)March 18, 2025
Avatrombopag maleate62207-025PowderDrugs for further processingMarch 12, 2025
Acetaminophen62207-078TabletExport onlyJanuary 2, 2025
Acetaminophen62207-234Tablet, extended releaseExport onlyJanuary 1, 2025
Acetaminophen extra strength62207-050TabletExport onlyJanuary 1, 2025
Acetaminophen62207-044TabletExport onlyJanuary 1, 2025

CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.